Skip to main content

. 1958 Aug 15;79(4):249–259.

Experiments in Immunity in Cancer ^{^*}

PMCID: PMC1830017 PMID: 13573269

252

Images in this article

Fig. 5
on p.249

Fig. 1
on p.252

Fig. 2
on p.254

Fig. 3
on p.256

Fig. 4a
on p.258

Fig. 4b
on p.258

Fig. 5a
on p.258

Fig. 5b
on p.258

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BRADNER W. T., CLARKE D. A., STOCK C. C. Stimulation of host defense against experimental cancer. I. Zymosan and sarcoma 180 in mice. Cancer Res. 1958 Apr;18(3):347–351. [PubMed] [Google Scholar]
DE ROETTH H. Chemical characteristics and varying degrees of malignancy in tumors of the human ovary. I. Oxygen consumption and lactic acid production. Cancer Res. 1957 Oct;17(9):833–840. [PubMed] [Google Scholar]
EICHWALD E. J. The mite of immunology. Cancer Res. 1956 Nov;16(10 Pt 1):918–920. [PubMed] [Google Scholar]
HIRAMOTO R., PRESSMAN D. Immunohistochemical staining properties of human skin and some related tumors. Cancer Res. 1957 Dec;17(11):1135–1137. [PubMed] [Google Scholar]
HOMBURGER F., TREGIER A., BORGES P. R. A transplantable leiomyosarcoma (HT-1) of the hamster. Cancer Res. 1957 Aug;17(7):659–659. [PubMed] [Google Scholar]
HUGGINS C. Control of cancers of man by endocrinologic methods; a review. Cancer Res. 1956 Oct;16(9):825–830. [PubMed] [Google Scholar]
KORNGOLD L. The distribution of human tissue antigens in five human tumors grown in rats or hamsters. Cancer Res. 1956 Nov;16(10 Pt 1):956–959. [PubMed] [Google Scholar]
KORNGOLD L., VAN LEEUWEN G. Immunological and electrophoretic studies of human tissue and tumor antigens. Cancer Res. 1957 Sep;17(8):775–779. [PubMed] [Google Scholar]
MOLOMUT N., SMITH L. W. Host-induced alterations in strain specificity of sarcoma I in mice: effect of active immunization of the host. Cancer Res. 1957 Feb;17(2):92–96. [PubMed] [Google Scholar]
PIKOVSKI M. A., SCHLESINGER M. Conditions influencing the degree of tolerance of mouse tumors in rats pretreated with mouse tissue. Cancer Res. 1956 Oct;16(9):848–855. [PubMed] [Google Scholar]
RICHER C. L., SELYE H. A syndrome of multiple telangiectases produced by a transplantable fibrosarcoma. Cancer Res. 1956 Oct;16(9):856–859. [PubMed] [Google Scholar]
ROSE N. R., SHULMAN S., WITEBSKY E. Studies of normal and malignant tissue antigens. Cancer Res. 1956 Oct;16(9):831–841. [PubMed] [Google Scholar]
SNELL G. D. Incompatibility reactions to tumor homotransplants with particular reference to the role of the tumor; a review. Cancer Res. 1957 Jan;17(1):2–10. [PubMed] [Google Scholar]
STANSLY P. G., RAMSEY D. S. Activity and regulation of the serum trypsin-inhibitor in mice. Cancer Res. 1957 Jul;17(6):572–578. [PubMed] [Google Scholar]
TARNOWSKI G. S., STOCK C. C. Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas. Cancer Res. 1957 Nov;17(10):1033–1039. [PubMed] [Google Scholar]
TOOLAN H. W. Permanently transplantable human tumors maintained in conditioned heterologous hosts: H. Chon. #1, H. Ep. #4, and H. Ad. #1. Cancer Res. 1957 Jun;17(5):418–420. [PubMed] [Google Scholar]

ACTIONS

PDF (5.1 MB)

RESOURCES